论文部分内容阅读
目的:本实验的课题在于探讨二羟丙茶碱联合氨溴索治疗急性发作期慢性支气管炎的临床预期效果。方法:先根据随机数字法对112例本院2015年2月~2017年3月期间收治的急性发作期慢性支气管炎患者进行分组,再对实验组56例患者采用二羟丙茶碱联合氨溴索治疗,对照组56例采用常规治疗,对比两组总有效率、不良反应发生率与临床指标。结果:两组不良反应发生率对比不具有统计学意义(P>0.05);实验组急性发作期慢性支气管炎患者总有效率高于对照组,临床指标都改善于对照组,均有统计学差异(P<0.05)。结论:急性发作期慢性支气管炎患者的总有效率可通过二羟丙茶碱联合氨溴索治疗显著提高,止咳时间、肺啰音消失时间与化痰时间能够明显缩减,用药安全性高,值得推广。
OBJECTIVE: The aim of this study is to investigate the clinical effect of dihydroxy-theophylline combined with ambroxol on acute exacerbation of chronic bronchitis. Methods: According to the random number method, 112 patients with acute exacerbation of chronic bronchitis admitted from February 2015 to March 2017 in our hospital were divided into groups, and 56 patients in the experimental group were treated with diprophylline combined with ambroxol Cable treatment, control group of 56 patients treated with conventional treatment, the total effective rate was compared, the incidence of adverse reactions and clinical indicators. Results: There was no significant difference in the incidence of adverse reactions between the two groups (P> 0.05). The total effective rate of acute exacerbation chronic bronchitis patients in the experimental group was higher than that in the control group, and the clinical indexes were all improved in the control group (P <0.05). Conclusion: The total effective rate of acute exacerbation of chronic bronchitis patients can be significantly increased by diprophylline combined with ambroxol treatment, cough time, pulmonary vocal disappearance time and phlegm time can be significantly reduced, medication safety is high, it is worth Promotion.